News
HEPA
0.6500
-1.37%
-0.0091
Weekly Report: what happened at HEPA last week (1021-1025)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/25 12:07
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/25 10:05
Weekly Report: what happened at HEPA last week (1014-1018)?
Weekly Report · 10/21 10:19
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/18 12:09
Weekly Report: what happened at HEPA last week (1007-1011)?
Weekly Report · 10/14 10:35
Weekly Report: what happened at HEPA last week (0930-1004)?
Weekly Report · 10/07 10:28
Weekly Report: what happened at HEPA last week (0923-0927)?
Weekly Report · 09/30 10:24
Weekly Report: what happened at HEPA last week (0916-0920)?
Weekly Report · 09/23 10:24
Weekly Report: what happened at HEPA last week (0909-0913)?
Weekly Report · 09/16 10:18
Weekly Report: what happened at HEPA last week (0902-0906)?
Weekly Report · 09/09 10:24
Pharma Two B and Hepion Pharmaceuticals Files Registration Statement On Form F-4 Related to Proposed Merger; Proposed Transaction Expected To Close In Q4
Benzinga · 09/04 13:28
PHARMA TWO B AND HEPION PHARMACEUTICALS, INC. ANNOUNCE FILING OF REGISTRATION STATEMENT ON FORM F-4 RELATED TO PROPOSED MERGER
Reuters · 09/04 13:25
Weekly Report: what happened at HEPA last week (0826-0830)?
Weekly Report · 09/02 10:27
Weekly Report: what happened at HEPA last week (0819-0823)?
Weekly Report · 08/26 10:25
Weekly Report: what happened at HEPA last week (0812-0816)?
Weekly Report · 08/19 10:17
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q2 2024
Investorplace · 08/14 01:56
Based on the provided financial report articles, the title of the article is likely to be: "Quarterly Report (Q2) for the period ended June 30, 2024, of Company 0001583771" Please note that the title may vary depending on the specific content and structure of the article.
Press release · 08/13 20:24
Weekly Report: what happened at HEPA last week (0805-0809)?
Weekly Report · 08/12 10:19
HEPION PHARMACEUTICALS INC: JOHN BRANCACCIO APPOINTED INTERIM CEO AND INTERIM CFO
Reuters · 08/07 13:05
More
Webull provides a variety of real-time HEPA stock news. You can receive the latest news about Hepion Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About HEPA
Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of drug therapy for treatment of chronic liver diseases. The Company is developing a treatment for non-alcoholic steatohepatitis (NASH), hepatocellular carcinoma (HCC), and other chronic liver diseases. Its cyclophilin inhibitor, rencofilstat, is being developed to offer benefits to address multiple complex pathologies related to the progression of liver disease. It is developing rencofilstat as its lead molecule. Rencofilstat is a compound that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulate protein folding, in addition to other activities. It has developed and maintains an artificial intelligence deep machine learning (AI/ML) platform designed to understand disease processes and identify patients that are rencofilstat responders. In addition, its AI/ML can be used to further NASH and HCC clinical development programs.